260 related articles for article (PubMed ID: 21513120)
1. [Myocardial no-reflow phenomenon: recent knowledges].
Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
[TBL] [Abstract][Full Text] [Related]
2. Myocardial no-reflow in humans.
Niccoli G; Burzotta F; Galiuto L; Crea F
J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
[TBL] [Abstract][Full Text] [Related]
3. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
[TBL] [Abstract][Full Text] [Related]
6. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Monassier JP
Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
[TBL] [Abstract][Full Text] [Related]
7. Management of the no-reflow phenomenon.
Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
[TBL] [Abstract][Full Text] [Related]
8. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
9. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
10. Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment.
Wong DT; Puri R; Richardson JD; Worthley MI; Worthley SG
Int J Cardiol; 2013 Sep; 167(5):1798-806. PubMed ID: 23357047
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
[TBL] [Abstract][Full Text] [Related]
12. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
13. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
[TBL] [Abstract][Full Text] [Related]
14. High cholesterol in patients with ECG signs of no-reflow after myocardial infarction.
Dobrzycki S; Kozuch M; Kamiński K; Korecki J; Ostasz A; Podgrudna E; Bonda T; Musiał WJ
Rocz Akad Med Bialymst; 2003; 48():118-22. PubMed ID: 14737956
[TBL] [Abstract][Full Text] [Related]
15. Myocardial 'no-reflow' prevention.
Magro M; Springeling T; van Geuns RJ; Zijlstra F
Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
[TBL] [Abstract][Full Text] [Related]
19. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
20. Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction.
Niccoli G; Andreotti F; Marzo F; Cecchetti S; Santucci E; D'Amario D; Pafundi T; Cosentino N; Crea F
Eur J Clin Invest; 2011 Nov; 41(11):1210-9. PubMed ID: 21492156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
